Skip to content

Investigator

Danielle L Swaney

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · funded by NIA, NIAID, NINDS

Companies
2

Resolved onto their grants.

Grants
7

Federal awards on file.

Non-dilutive funding
$3.1M

Summed across those awards.

First award
Aug 17, 2018

Latest Jun 1, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Aberrant proteomes in tauopathy: revealing functional consequences via multimodal proteomics

    $817k

    Jun 1, 2025NIAUNIVERSITY OF CALIFORNIA, SAN FRANCISCONIH RePORTER · 11111785 (opens the source filing in a new tab)

  2. R01

    Aberrant proteomes in tauopathy: revealing functional consequences via multimodal proteomics

    $797k

    Jun 1, 2025NIAUNIVERSITY OF CALIFORNIA, SAN FRANCISCONIH RePORTER · 11336351 (opens the source filing in a new tab)

  3. U54

    Core 1 Krogan

    $358k

    Jul 15, 2022NIAIDUNIVERSITY OF CALIFORNIA, SAN FRANCISCONIH RePORTER · 11111408 (opens the source filing in a new tab)

  4. U54

    Core 1 Krogan

    $417k

    Jul 15, 2022NIAIDUNIVERSITY OF CALIFORNIA, SAN FRANCISCONIH RePORTER · 11369928 (opens the source filing in a new tab)

  5. U54

    Core B: Proteomics

    $132k

    Sep 1, 2021NINDSICAHN SCHOOL OF MEDICINE AT MOUNT SINAINIH RePORTER · 11170002 (opens the source filing in a new tab)

  6. U19

    CORE 2: Technology Core

    $267k

    Aug 17, 2018NIAIDUNIVERSITY OF CALIFORNIA, SAN FRANCISCONIH RePORTER · 11088226 (opens the source filing in a new tab)

  7. U19

    CORE 2: Technology Core

    $267k

    Aug 17, 2018NIAIDUNIVERSITY OF CALIFORNIA, SAN FRANCISCONIH RePORTER · 11521634 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources